Quantcast

Latest Valeant Pharmaceuticals Stories

2015-04-24 08:32:02

LAVAL, Quebec and TARRYTOWN, N.Y., April 24, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc.

2015-04-01 08:33:16

LAVAL, Quebec, April 1, 2015 /PRNewswire/ -- Salix Pharmaceuticals, Ltd. ("Salix"), a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc.

2015-04-01 08:32:52

LAVAL, Quebec, April 1, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.

2015-04-01 08:30:10

LAVAL, Quebec, April 1, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.

2015-03-27 12:26:49

LAVAL, Quebec, March 27, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.

2015-03-27 12:26:38

LONDON, March 27, 2015 /PRNewswire/ -- Report Details New study shows you commercial prospects for leading ophthalmic drug companies What does

2015-03-17 08:32:32

LAVAL, Quebec, March 17, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.

2015-03-16 16:26:49

LAVAL, Quebec, March 16, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that it has filed with the U.S.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related